Landos Biopharma (LABP) Short Interest Ratio & Short Volume → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free LABP Stock Alerts $22.21 -0.26 (-1.16%) (As of 03:50 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Landos Biopharma Short Interest DataCurrent Short Interest1,400 sharesPrevious Short Interest800 sharesChange Vs. Previous Month+75.00%Dollar Volume Sold Short$31,220.00Short Interest Ratio0.1 Days to CoverLast Record DateApril 30, 2024Outstanding Shares3,130,000 sharesFloat Size2,820,000 sharesShort Percent of Float0.05%Today's Trading Volume17,977 sharesAverage Trading Volume19,319 sharesToday's Volume Vs. Average93% Short Selling Landos Biopharma ? Sign up to receive the latest short interest report for Landos Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLABP Short Interest Over TimeLABP Days to Cover Over TimeLABP Percentage of Float Shorted Over Time Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Landos Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,400 shares $31,220.00 +75.0%0.1%0.1 $22.30 4/15/2024800 shares $17,256.00 -83.7%0.0%0 $21.57 3/31/20244,900 shares $105,252.00 +345.5%0.2%0.2 $21.48 3/15/20241,100 shares $7,304.00 No Change0.0%0.1 $6.64 2/29/20241,100 shares $6,974.00 -74.4%0.0%0.1 $6.34 2/15/20244,300 shares $23,478.00 +10.3%0.2%0.5 $5.46 Get the Latest News and Ratings for LABP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Landos Biopharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,900 shares $21,021.00 +18.2%0.1%0.5 $5.39 1/15/20243,300 shares $14,388.00 +120.0%0.1%0.5 $4.36 12/31/20231,500 shares $5,490.00 -48.3%0.1%0.2 $3.66 12/15/20232,900 shares $12,470.00 -60.3%0.1%0.4 $4.30 11/30/20237,300 shares $30,441.00 +15.9%0.3%1.1 $4.17 11/15/20236,300 shares $25,137.00 -57.1%0.2%1.1 $3.99 10/31/202314,700 shares $58,800.00 -10.9%0.5%2.5 $4.00 10/15/202316,500 shares $58,740.00 +96.4%0.6%3.1 $3.56 9/30/20238,400 shares $32,592.00 +2.4%0.3%1.3 $3.88 9/15/20238,200 shares $32,800.00 +46.4%0.3%0.8 $4.00 8/31/20235,600 shares $20,216.00 +40.0%0.2%0.4 $3.61 8/15/20234,000 shares $15,720.00 No Change0.1%0.2 $3.93 7/31/20234,000 shares $15,640.00 -77.9%0.1%0.2 $3.91 7/15/202318,100 shares $73,848.00 -4.2%0.6%0.8 $4.08 6/30/202318,900 shares $79,191.00 -10.0%0.7%0.8 $4.19 6/15/202321,000 shares $79,800.00 +159.3%0.8%1.1 $3.80 5/31/20238,100 shares $22,356.00 -87.6%0.3%0.4 $2.76 5/15/202365,200 shares $19,494.80 +1.9%0.2%0.4 $0.30 4/30/202364,000 shares $17,990.40 -43.6%0.2%0.3 $0.28 4/15/2023113,400 shares $32,874.66 -10.8%0.4%0.5 $0.29 3/31/2023127,100 shares $37,875.80 -22.9%0.5%0.4 $0.30 3/15/2023164,800 shares $42,188.80 -34.6%0.5%0.3 $0.26 2/28/2023252,100 shares $93,302.21 +6.2%0.7%0.4 $0.37 2/15/2023237,500 shares $91,390.00 +14.1%0.8%0.4 $0.38 1/31/2023208,100 shares $87,630.91 -63.1%0.7%0.4 $0.42 1/15/2023563,800 shares $229,466.60 +16.6%1.9%0.8 $0.41 12/30/2022483,700 shares $241,898.37 +33.6%1.7%0.8 $0.50 12/15/2022362,000 shares $139,225.20 +132.1%1.2%0.7 $0.38 11/30/2022156,000 shares $33,540.00 -6.7%0.5%0.5 $0.22 11/15/2022167,200 shares $46,816.00 +25.1%0.6%0.6 $0.28 10/31/2022133,700 shares $45,203.97 +118.8%0.5%0.5 $0.34 10/15/202261,100 shares $39,715.00 -49.3%0.2%0.5 $0.65 9/30/2022120,400 shares $78,260.00 +44.2%0.4%1.1 $0.65 9/15/202283,500 shares $87,675.00 -35.6%0.3%0.7 $1.05Everybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. 8/31/2022129,700 shares $116,730.00 +7.8%0.5%1.2 $0.90 8/15/2022120,300 shares $120,300.00 +20.3%0.4%1.2 $1.00 7/31/2022100,000 shares $79,370.00 -24.9%0.3%0.9 $0.79 7/15/2022133,200 shares $106,560.00 +16.4%0.4%1.2 $0.80 6/30/2022114,400 shares $83,271.76 -62.5%0.4%1 $0.73 6/15/2022305,400 shares $261,727.80 -11.7%1.0%2.6 $0.86 5/31/2022345,900 shares $251,123.40 +17.4%1.1%3.4 $0.73 5/15/2022294,700 shares $199,511.90 +13.4%0.9%3.1 $0.68 4/30/2022259,800 shares $248,109.00 +12.1%0.8%2.2 $0.96 4/15/2022231,700 shares $289,625.00 +4.9%0.7%2.2 $1.25 3/31/2022220,900 shares $326,932.00 +2.8%0.7%2.2 $1.48 3/15/2022214,800 shares $330,792.00 +3.1%0.7%2.2 $1.54 2/28/2022208,400 shares $443,892.00 +23.8%0.7%1.9 $2.13 2/15/2022168,400 shares $368,796.00 +15.8%0.5%1.5 $2.19 1/31/2022145,400 shares $498,722.00 +3.8%0.5%1.3 $3.43 1/15/2022140,100 shares $521,172.00 -5.7%0.5%1.5 $3.72 12/31/2021148,500 shares $712,800.00 +53.4%0.5%1.4 $4.80 12/15/202196,800 shares $520,784.00 +2.9%0.3%0.9 $5.38 11/30/202194,100 shares $680,343.00 -70.0%0.3%1 $7.23 11/15/2021313,700 shares $4.39 million -6.3%1.1%3.9 $14.01 10/29/2021334,900 shares $4.51 million +0.6%1.2%5.2 $13.46 10/15/2021333,000 shares $4.97 million +6.7%1.2%5.5 $14.92 9/30/2021312,200 shares $4.56 million -17.9%1.1%6.2 $14.60 9/15/2021380,100 shares $5.85 million +1.9%1.4%8.1 $15.38 8/31/2021372,900 shares $4.95 million +2.3%1.4%8.6 $13.28 8/13/2021364,700 shares $4.91 million No Change1.3%8.1 $13.47 LABP Short Interest - Frequently Asked Questions What is Landos Biopharma's current short interest? Short interest is the volume of Landos Biopharma shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 1,400 shares of LABP short. 0.05% of Landos Biopharma's shares are currently sold short. Learn More on Landos Biopharma's current short interest. What is a good short interest percentage for Landos Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.05% of Landos Biopharma's floating shares are currently sold short. Is Landos Biopharma's short interest increasing or decreasing? Landos Biopharma saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 1,400 shares, an increase of 75.0% from the previous total of 800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Landos Biopharma's float size? Landos Biopharma currently has issued a total of 3,130,000 shares. Some of Landos Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Landos Biopharma currently has a public float of 2,820,000 shares. How does Landos Biopharma's short interest compare to its competitors? 0.05% of Landos Biopharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Landos Biopharma: Leap Therapeutics, Inc. (5.57%), Celularity Inc. (5.64%), Journey Medical Co. (4.07%), MediciNova, Inc. (0.46%), InflaRx (0.22%), Marinus Pharmaceuticals, Inc. (9.10%), Lantern Pharma Inc. (6.15%), SCYNEXIS, Inc. (2.58%), Aileron Therapeutics, Inc. (0.98%), Tempest Therapeutics, Inc. (9.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Landos Biopharma stock? Short selling LABP is an investing strategy that aims to generate trading profit from Landos Biopharma as its price is falling. LABP shares are trading down $0.26 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Landos Biopharma? A short squeeze for Landos Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LABP, which in turn drives the price of the stock up even further. How often is Landos Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LABP, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: LPTX Short Interest Data CELU Short Interest Data DERM Short Interest Data MNOV Short Interest Data IFRX Short Interest Data MRNS Short Interest Data LTRN Short Interest Data SCYX Short Interest Data ALRN Short Interest Data TPST Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LABP) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDoes this make you sick?Allegiance GoldThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts